Robert A. Kyle

4.6k total citations
45 papers, 2.2k citations indexed

About

Robert A. Kyle is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Robert A. Kyle has authored 45 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 26 papers in Hematology and 10 papers in Oncology. Recurrent topics in Robert A. Kyle's work include Multiple Myeloma Research and Treatments (24 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (18 papers) and Glycosylation and Glycoproteins Research (5 papers). Robert A. Kyle is often cited by papers focused on Multiple Myeloma Research and Treatments (24 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (18 papers) and Glycosylation and Glycoproteins Research (5 papers). Robert A. Kyle collaborates with scholars based in United States, Cuba and Italy. Robert A. Kyle's co-authors include M. A. Gertz, Philip R. Greipp, Morie A. Gertz, Rafaël Fonseca, S. Vincent Rajkumar, Thomas E. Witzig, Joan Bladé, Angela Dispenzieri, John A. Lust and Brian Van Ness and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Hepatology.

In The Last Decade

Robert A. Kyle

44 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert A. Kyle United States	27	1.4k	1.1k	586	409	225	45	2.2k
Taxiarchis Kourelis United States	28	1.7k 1.2×	1.1k 1.0×	813 1.4×	612 1.5×	199 0.9×	215	2.7k
Yoshio Kanayama Japan	25	946 0.7×	865 0.8×	262 0.4×	403 1.0×	90 0.4×	78	3.1k
Manuel Aivado United States	31	1.2k 0.9×	2.1k 1.9×	508 0.9×	843 2.1×	82 0.4×	89	3.3k
Peter Gimsing Denmark	31	1.9k 1.3×	2.1k 1.9×	1.4k 2.4×	301 0.7×	42 0.2×	111	3.1k
Fumio Bessho Japan	29	863 0.6×	1.1k 1.0×	357 0.6×	286 0.7×	172 0.8×	102	2.4k
Merav Leiba Israel	23	824 0.6×	929 0.8×	930 1.6×	224 0.5×	55 0.2×	77	2.0k
Joseph Michaeli United States	18	912 0.6×	722 0.7×	694 1.2×	248 0.6×	23 0.1×	55	2.0k
Thirusha Lane United Kingdom	25	2.5k 1.7×	356 0.3×	528 0.9×	439 1.1×	839 3.7×	66	2.8k
Edward C. Bradley United States	18	762 0.5×	650 0.6×	585 1.0×	755 1.8×	29 0.1×	32	2.0k
Peter Browett New Zealand	22	453 0.3×	724 0.7×	508 0.9×	442 1.1×	86 0.4×	91	1.7k

Countries citing papers authored by Robert A. Kyle

Since Specialization

Citations

This map shows the geographic impact of Robert A. Kyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Kyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Kyle more than expected).

Fields of papers citing papers by Robert A. Kyle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Kyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Kyle. The network helps show where Robert A. Kyle may publish in the future.

Co-authorship network of co-authors of Robert A. Kyle

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Kyle. A scholar is included among the top collaborators of Robert A. Kyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Kyle. Robert A. Kyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dispenzieri, Angela, S. Vincent Rajkumar, Morie A. Gertz, et al.. (2007). Treatment of Newly Diagnosed Multiple Myeloma Based on Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART): Consensus Statement. Mayo Clinic Proceedings. 82(3). 323–341. 113 indexed citations

Kyle, Robert A.. (2002). Diagnosis of multiple myeloma. Seminars in Oncology. 29(6). 2–4. 12 indexed citations

Kyle, Robert A.. (2001). Therapeutic application of thalidomide in multiple myeloma. Seminars in Oncology. 28(6). 583–587. 20 indexed citations

Gertz, M. A., Angela Dispenzieri, Bruce D. Cheson, et al.. (2000). A multicenter phase II trial of 4'-IODO-4'-deoxydoxorubicin (IDOX) in primary amyloidosis (AL). 96. 1 indexed citations

Fonseca, Rafaël, James D. Hoyer, Syed M. Jalal, et al.. (1999). Clinical Significance of the Translocation (11;14)(q13;q32) in Multiple Myeloma. Leukemia & lymphoma. 35(5-6). 599–605. 23 indexed citations

Fonseca, Rafaël, Gregory Ahmann, Syed M. Jalal, et al.. (1998). Chromosomal abnormalities in systemic amyloidosis. British Journal of Haematology. 103(3). 704–710. 39 indexed citations

Bladé, Joan & Robert A. Kyle. (1998). Multiple Myeloma in Young Patients: Clinical Presentation and Treatment Approach. Leukemia & lymphoma. 30(5-6). 493–501. 68 indexed citations

Kyle, Robert A. & Marc A. Shampo. (1997). Thomas Huckle Weller and the Successful Culture of Poliovirus. Mayo Clinic Proceedings. 72(5). 422–422. 1 indexed citations

Gertz, Morie A., et al.. (1997). Multiple myeloma associated with diffuse osteosclerotic bone lesions: A clinical entity distinct from osteosclerotic myeloma (POEMS syndrome). American Journal of Hematology. 56(4). 288–293. 37 indexed citations

10.

Kyle, Robert A.. (1995). 4Monoclonal gammopathy of undetermined significance (MGUS). Baillière s Clinical Haematology. 8(4). 761–781. 43 indexed citations

11.

Gertz, Morie A. & Robert A. Kyle. (1993). Phase II trial of recombinant interferon alfa‐2 in the treatment of primary systemic amyloidosis. American Journal of Hematology. 44(2). 125–128. 20 indexed citations

12.

Kyle, Robert A., et al.. (1992). Primary systemic amyloidosis. Journal of Internal Medicine. 232(6). 523–524. 19 indexed citations

13.

Heilman, Raymond L., Jorge A. Velosa, Keith E. Holley, Kenneth P. Offord, & Robert A. Kyle. (1992). Long-Term Follow-Up and Response to Chemotherapy in Patients With Light-Chain Deposition Disease. American Journal of Kidney Diseases. 20(1). 34–41. 99 indexed citations

14.

Kyle, Robert A. & Morie A. Gertz. (1990). Systemic amyloidosis. Critical Reviews in Oncology/Hematology. 10(1). 49–87. 50 indexed citations

15.

Kyle, Robert A.. (1989). Dysproteinemias and cryoglobulinemia. Current Opinion in Rheumatology. 1(2). 221–226. 4 indexed citations

16.

Witzig, Thomas E., Nick J. Gonchoroff, J A Katzmann, et al.. (1988). Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies.. Journal of Clinical Oncology. 6(6). 1041–1046. 69 indexed citations

17.

Kyle, Robert A. & G J Gleich. (1982). IgG subclasses in monoclonal gammopathy of undetermined significance.. PubMed. 100(5). 806–14. 13 indexed citations

18.

Kyle, Robert A. & Philip R. Greipp. (1978). 3. The Laboratory Investigation of Monoclonal Gammopathies. Mayo Clinic Proceedings. 53(11). 719–739. 43 indexed citations

19.

Kyle, Robert A. & Lila R. Elveback. (1976). Management and Prognosis of Multiple Myeloma. Mayo Clinic Proceedings. 51(12). 751–760. 34 indexed citations

20.

Perry, Michael C. & Robert A. Kyle. (1975). The Clinical Significance of Bence Jones Proteinuria. Mayo Clinic Proceedings. 50(5). 234–238. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact